Lucinactant for the prevention of respiratory distress syndrome in premature infants

By Jordan Brian K   Donn Steven M  

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 2, 2013-03 ,pp. : 115-121

Informa Healthcare

Access to resources Recommend Favorite

The Short-Term Outcome of a Large Cohort of Very Preterm Infants Treated with Poractant Alfa (Curosurf®) for Respiratory Distress Syndrome: A Postmarketing Phase IV Study

By Lamboley-Gilmert G.   Lacaze-Masmonteil T.  

Pediatric Drugs, Vol. 5, Iss. 9, 2003-01 ,pp. : 639-645

Adis International

Access to resources Recommend Favorite

Acute respiratory distress syndrome following treatment for babesiosis

By Jr Ryland P Byrd   Roy Thomas M  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 11, 2002-11 ,pp. : 1541-1542

Informa Healthcare

Access to resources Recommend Favorite

Current Perspectives on the Drug Treatment of Neonatal Respiratory Distress Syndrome

By Sweet D.G.   Halliday H.L.  

Pediatric Drugs, Vol. 1, Iss. 1, 1999-01 ,pp. : 19-30

Adis International

Access to resources Recommend Favorite

Pharmacotherapy for Prevention and Treatment of Acute Respiratory Distress Syndrome: Current and Experimental Approaches

By Bosma Karen J.   Taneja Ravi   Lewis James F.  

Drugs, Vol. 70, Iss. 10, 2010-07 ,pp. : 1255-1282

Adis International

Access to resources Recommend Favorite